HLA-DR in brazilian patients with polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA)

Disease Markers

Volumn 26, Issue 3, 2009, Pages 105-109

  De Lira Freire, Alzírton ^a   Conde, Roseneide Aparecida ^a   Bertolo, Manoel Barros ^a   Costallat, Lílian Teresa Lavras ^a   Levy Neto, Maurício ^b   Fernandes, Sandra Regina Muchinechi ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Autoimmunity; HLA; Microscopic polyangiitis; Polyarteritis nodosa; Vasculitis

Indexed keywords

HLA DR ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BRAZIL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; HUMAN; MALE; MICROSCOPIC POLYANGIITIS; POLYARTERITIS NODOSA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SYSTEMIC VASCULITIS;

EID: 68649090213     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/258745     Document Type: Article

References (24)

1. R.W. Lightfoot Jr, B.A. Michel, D.A. Bloch et al., The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa, Arthritis Rheum 33 (1990), 1088-1093.
2. J.C. Jennette, R.J. Falk, K. Andrassy et al., Nomenclature of systemic vasculitides: proposal of an international consensus conference, Arthritis Rheum 37 (1994), 187-192.
3. B. Hellmich, O. Flossmann, W.L. Gross et al., EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis, Ann Rheum Dis 66 (2007), 605-617.
4. R. Nowack, H. Lehmann, L.F. Flores-Suárez, A. Nanhou and F.J. Van Der Woude, Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis, Am J Kidney Dis 34 (1999), 364-373.
5. P. Fietta, Systemic vasculitides: immunogenetics and familial clustering, Clin Exp Rheumatol 22 (2004), 238-251.
6. S. Borgmann and M. Haubitz, Genetic impact of pathogenesis and prognosis of ANCA - associated vasculitides, Clin Exp Rheumatol 22(suppl 36) (2004), S79-86.
7. R. Harris and H.P. Jones, Polyarteritis nodosa in identical twins, Ann Phys Med 10 (1970), 241-242.
8. R. Leff, W.V. Harrer, J.C. Baylis, L.Jackson and K. Faber, Pol-yarteritis nodosa in two siblings, Am J Dis Child 121 (1971), 67-70.
9. J.D. Reveille, R.E. Goodman, B.O. Barger, R.T. Acton, Familial polyarteritis nodosa: a serologic and immunogenetic analysis, J Rheumatol 16 (1989), 181-185.
10. M. Rottem, M.C. Frances, A.S. Fauci and G.S. Hoffmam, Familial Vasculitis: report of 2 families, J Rheumatol 21 (1994), 561-563.
11. J.C. Mason, M.R. Cowie, K.A. Davies, J.B. Schofield, J.Cambridge, M.J. Walport, Familial polyarteritis nodosa, Arthritis Rheum 37 (1994), 1249-1253.
12. G. Barbiano di Belgiojoso, A. Genderini, R.A. Sinico et al., Acute renal failure due to microscopic polyarteritis with the same histological and clinical patterns in a father and his son, Contrib Nephrol 94 (1991), 107-114.
13. L. Heuze-Claudot, B. Leroy, A. Chevailler et al., A familial ANCA-associated pulmonary-renal syndrome, Clin Exp Immunol 93(suppl 2) (1993), S40.
14. C.F. Franssen, J.C. Ter Maaten and S.J. Hoorntje, Brother and sister with myeloperoxidase associatedautoimunedisease, Ann Rheum Dis 53 (1994), 213.
15. R.A. Luqmani, P.A. Bacon and R.J. Moots, Birmingham Vas-culitis Activity Score (BVAS) in systemic necrotizing vasculitis, Q J Med 87 (1994), 671-68.
16. L. Guillevin, F. Lhote, M. Gayraud et al., Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients, Medicine 75 (1996), 17-28.
17. L. Guillevin, B. Durand-Gasselin, R. Cevallos et al., Microscopic polyangiitis. Clinical and laboratory findings in eighty-five patients, Arthritis Rheum 42 (1999), 421-430.
18. K.A. Boki, U. Dafni, G.A. Karpouzas, C. Papasteriades, A.A. Drosos and H.M. Moutsopoulos, Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients, Br J Rheumatol 36 (1997), 1059-1066.
19. K.B. Elkon, D.C. Sutherland, A.J. Rees, G.R.V. Hughes and J.R. Batchelor, HLA antigen frequencies in systemic vas-culitis: increase in HLA-DR2 in Wegener's granulomatosis, Arthritis Rheum 26 (1983), 102-105.
20. S.J.W. Spencer, A. Burns, G. Gaskin, C.D. Pusey and A.J. Rees, HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens, Kidney Int 41 (1992), 1059-1063.
21. C. Papasteriades, D. Hatziyannakos, M. Siakotos et al., HLA antigens in microscopic polyarteritis with renal involvement, Dis Markers 13 (1997), 117-122.
22. E.C. Hagen, C.A. Stegeman, J. D'amaro et al., Decreased frequency of HLA-DR13DR6 in Wegener's granulomatosis, Kidney Int 48 (1995), 801-805.
23. M. Gencik, S. Borgmann, R. Zahn et al., Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis, Clin Exp Immunol 117 (1999), 412-417.
24. N. Tsuchiya, S. Kobayashi, A. Kawasaki et al., Genetic background of japanese patients with antineutrophil cyto-plasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis, J Rheumatol 30 (2003), 1534-1540.